Page last updated: 2024-08-24

gemcitabine and heparitin sulfate

gemcitabine has been researched along with heparitin sulfate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Barone, D; Bekaii-Saab, T; Flaherty, KT; Krause, S; Mahalingam, D; O'Reilly, EM; Richards, DA; Roach, JM; Rosano, M; Ryan, DP; Shao, SH; Wolf, J; Yu, KH	1

Trials

1 trial(s) available for gemcitabine and heparitin sulfate

Article	Year
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma. European journal of cancer (Oxford, England : 1990), 2020, Volume: 132 Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Deoxycytidine; Double-Blind Method; Female; Follow-Up Studies; Gemcitabine; Heparitin Sulfate; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Prognosis; Survival Rate	2020

Article

Year

Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma.

European journal of cancer (Oxford, England : 1990), 2020, Volume: 132

Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Deoxycytidine; Double-Blind Method; Female; Follow-Up Studies; Gemcitabine; Heparitin Sulfate; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Prognosis; Survival Rate

2020